3 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride...

FDA Drug Recall #D-1414-2016 — Class II — May 5, 2016

Recall Summary

Recall Number D-1414-2016
Classification Class II — Moderate risk
Date Initiated May 5, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Pharmedium Services, LLC
Location Lake Forest, IL
Product Type Drugs
Quantity 345 bags

Product Description

3 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Hospira LifeCare Bag, Service Code 2H8180 (NDC 61553-180-52), 250 mL in 250 mL Hospira LifeCare Bag Service Code 2H8262 (NDC 61553-262-50), 250 mL in 250 mL Baxter Intravia Bag, Service Code 2K8180 (NDC 61553-180-02), Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141

Reason for Recall

Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Distribution Pattern

Nationwide

Lot / Code Information

Service Code 2H8180 , Lot Number 160450152M , Exp. Date 5/11/2016 ; Service Code 2H8180 , Lot Number 160830040M , Exp. Date 6/17/2016 ; Service Code 2H8262 , Lot Number 160380102M , Exp. Date 5/8/2016 ; Service Code 2H8262 , Lot Number 160750131M , Exp. Date 6/14/2016 ; Service Code 2H8262 , Lot Number 161080121M , Exp. Date 7/17/2016 ; Service Code 2K8180 , Lot Number 160460038C , Exp. Date 5/10/2016 ; Service Code 2K8180 , Lot Number 160480026C , Exp. Date 5/12/2016 ; Service Code 2K8180 , Lot Number 160550022C , Exp. Date 5/19/2016 ; Service Code 2K8180 , Lot Number 160620021C , Exp. Date 5/26/2016 ; Service Code 2K8180 , Lot Number 160680038C , Exp. Date 6/1/2016 ; Service Code 2K8180 , Lot Number 160760022C , Exp. Date 6/9/2016 ; Service Code 2K8180 , Lot Number 160770042C , Exp. Date 6/10/2016 ; Service Code 2K8180 , Lot Number 160830034C , Exp. Date 6/16/2016 ; Service Code 2K8180 , Lot Number 160900094C , Exp. Date 6/23/2016 ; Service Code 2K8180 , Lot Number 160940033C , Exp. Date 6/27/2016 ; Service Code 2K8180 , Lot Number 160970035C , Exp. Date 6/30/2016 ; Service Code 2K8905 , Lot Number 160810187M , Exp. Date 6/11/2016 ; Service Code 2K8905 , Lot Number 160890186M , Exp. Date 6/18/2016 ; Service Code 2K8975 , Lot Number 160550132M , Exp. Date 5/15/2016 ; Service Code 2K8975 , Lot Number 160610229M , Exp. Date 5/22/2016 ; Service Code 2K8975 , Lot Number 160770165M , Exp. Date 6/7/2016 ;

Other Recalls from Pharmedium Services, LLC

Recall # Classification Product Date
D-1087-2020 Class II rocuronium Bromide, 10 mg per mL, 50 mg per 5 m... Mar 16, 2020
D-1088-2020 Class II ePHEDrine Sulfate, 5 mg per mL, 25 mg per 5 mL ... Mar 16, 2020
D-1085-2020 Class II fentaNYL Citrate 10 mcg per mL, 2,500 mcg per 2... Mar 16, 2020
D-1082-2020 Class II nICARdipine HCl (0.1 mg/mL) 1 mg/10mL, in 0.9%... Mar 16, 2020
D-1083-2020 Class II rocuronium Bromide 10 mg per mL 50 mg per 5 mL,... Mar 16, 2020

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.